Last reviewed · How we verify
NCT04221867: ESOGRAFT
Feasibility and Therapeutic Potential of Free Fat Grafts in the Treatment of Esophageal Strictures (ESOGRAFT)
NA trial testing Stricture dilation with CRE balloon in Esophageal Stricture in 20 participants. Status unknown.
1 March 2022
Quick facts
| Lead sponsor | Hannes Kortekangas |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 15 August 2021 |
| Primary completion | 1 March 2022 |
| Estimated completion | 1 March 2023 |
Drugs / interventions tested
- Stricture dilation with CRE balloon
- Autologous fat grafting
Conditions studied
- Esophageal Stricture — all drugs for Esophageal Stricture →
- Fat Graft — all drugs for Fat Graft →
Sponsor
Hannes Kortekangas
Who can join
Adults 18 to 99, any sex, with Esophageal Stricture or Fat Graft. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study the investigators investigate the feasibility and therapeutic potential of free autologous fat grafting combined to dilation therapy in the treatment of benign esophageal strictures.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04221867
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Esophageal Stricture
Currently open trials in the same condition.
- NCT06514079 — Role of Topical Steroid Injection With Refractory Benign Esophageal Stricture Endoscopic Dilatation in Children · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04221867 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hannes Kortekangas
- Last refreshed: 2 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04221867.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing